Patch pump could simplify diabetes care

NCT ID NCT07403565

Completed Disease control Sponsor: Suzhou Hechun Medical Technology Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new insulin patch pump in 161 adults with type 1 or type 2 diabetes who needed intensive insulin therapy. Participants used either the new patch pump or a standard pump for 7 days in a hospital. Researchers measured changes in average blood sugar levels to see if the patch pump worked as well as the standard one.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Insulin Patch Pump System (a wearable device that delivers insulin)
What this could lead to: If successful, this could offer people with diabetes a more convenient and effective way to manage their blood sugar with a patch pump instead of a traditional pump.
What could go wrong: This was a short, 7-day inpatient study with only 161 participants, so long-term benefits and real-world use are not yet proven. The device may not work as well for everyone or could have technical issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES TYPE 2 DIABETES

Contacts and locations

Locations

Peking University First Hospital

Beijing, Beijing Municipality, China
Sir Run Run Hospital, Nanjing Medical University

Nanjing, Jiangsu, China
Sun Yat-sen Memorial Hosipital,Sun Yat-sen University

Guangzhou, Guangdong, China
The Fourth Hospital of Harbin Medical University

Harbin, Heilongjiang, China
The Second Affiliated Hospital of Shantou University Medical College

Shantou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.